How your CES1 genes affect remimazolam during anesthesia
Treatments studied
This study looks at whether a person’s genetic type (CES1) changes how the anesthesia medicine remimazolam works and how much it affects the depth of sleep. It may help doctors choose safer, better-matched anesthesia for future patients having elective surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 19 to 70
- Be having an elective (planned) surgery
- Be an ASA health status 1 or 2 (generally healthy or mild disease)
- Not receive regional anesthesia (like nerve blocks for the whole area)
- Have stable key health tests: blood pressure not too high, diabetes not poorly controlled, liver tests not too abnormal, and kidney function not too low
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of giving the sedative remimazolam during brain bypass surgery. It looks at which method uses less medicine. If you are having this surgery, you may be able to join.
This study tests a computerized dosing system for a sedation medicine called remimazolam during general anesthesia. It is for adults having planned surgery and aims to see if the computer-guided dosing is safe and effective.
This trial tests a new sedative called remimazolam for people having planned heart surgery with a heart-lung machine. It aims to see if it works well and is safe for keeping you asleep during the operation.
This study tests whether a combination of two medicines (esketamine and remimazolam) can help people sleep better and feel less anxious after surgery. Researchers want to see if this approach works better than standard care.
This trial tests a sedative called remimazolam for women undergoing gynecological surgeries like hysterectomy or fibroid removal. The goal is to see how it works and if it's a good option for anesthesia.
This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.